2024 |
Novartis AG - ADR
|
Independent Director |
430 K |
0.0 % |
2024 |
Aramark
|
Independent Director |
290.0 K |
-2.5 % |
2024 |
Integral Ad Science Holding Corp
|
Independent Director |
- |
- |
2024 |
Dexcom Inc
|
Independent Director |
- |
- |
2023 |
Novartis AG - ADR
|
Independent Director |
430 K |
1.6 % |
2023 |
Dexcom Inc
|
Independent Director |
346.5 K |
9.2 % |
2023 |
Aramark
|
Independent Director |
297.6 K |
9.9 % |
2023 |
Integral Ad Science Holding Corp
|
Independent Director |
250.0 K |
-0.0 % |
2022 |
Novartis AG - ADR
|
Independent Director |
423.3 K |
11.9 % |
2022 |
Dexcom Inc
|
Independent Director |
317.4 K |
1.0 % |
2022 |
Aramark
|
Independent Director |
270.8 K |
14.5 % |
2022 |
Integral Ad Science Holding Corp
|
Independent Director |
250.0 K |
11.1 % |
2021 |
Novartis AG - ADR
|
Independent Director |
378.3 K |
- |
2021 |
Dexcom Inc
|
Independent Director |
314.4 K |
-1.4 % |
2021 |
Aramark
|
Independent Director |
236.5 K |
- |
2021 |
Integral Ad Science Holding Corp
|
Independent Director |
225 K |
- |
2020 |
Dexcom Inc
|
Independent Director |
318.9 K |
-28.2 % |
2020 |
Aramark
|
Independent Director |
- |
- |
2020 |
Novartis AG - ADR
|
Independent Director |
- |
- |
2020 |
Integral Ad Science Holding Corp
|
Independent Director |
- |
- |
2019 |
Dexcom Inc
|
Independent Director |
444.0 K |
- |